Delivery Order SPE2DB22D3004-SPE2DB25FRN07
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,501.90 delivery order to AmerisourceBergen Drug Corp for Gadavist 10 mmol/10 ml vials, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- This is a $2,366.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the pharmaceutical product Gadavist, a 10 milliliter vial containing 10 millimoles per milliliter. The delivery order has a completion date of June 11, 2025 and is not set aside for any small business categories. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,962.44, is for the supply of Gadavist, a 10 mmol/10 ml vial medication, with a period of performance through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.10, is for the delivery of Gadavist, a medication used in magnetic resonance imaging (MRI) procedures. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,083.96, is for the delivery of Gadavist 7.5 millimolar/7.5 milliliter vials. It is a firm fixed-price contract with a period of performance ending on May 5, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $1,978.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562056165 Gadavist 1 mmol/ml bulk vials. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver 30 ml vials of Gadavist, a gadolinium-based contrast agent, to a location in Conshohocken, Pennsylvania by September 6, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
- This is a $1,704.90 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of Gadavist 1 mmol/ml bulk vials, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Gadavist 1 mmol/ml bulk vial (30 ml), a pharmaceutical product, at a firm fixed price of $1,704.90. The contract has an ultimate completion date of May 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $305.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561730790 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML. Performance will take place in Conshohocken, Pennsylvania under the terms of the contract lasting from August 7 to August 8, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Drug Corporation will deliver the requested dosage of a magnetic resonance contrast agent to the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at approximately $719 to Amerisourcebergen Drug Corporation for Gadavist, a contrast agent used in magnetic resonance imaging. To be performed over a one day period in Conshohocken, Pennsylvania, the firm fixed price contract calls for the delivery of 10 millimoles of Gadavist in 10 milliliter vials. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, Amerisourcebergen will fulfill this order...